Treating Burkitt's lymphoma in Malawi, Cameroon, and Ghana
- 1 June 2008
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 9 (6), 512-513
- https://doi.org/10.1016/s1470-2045(08)70139-6
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphomaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Kenya and Uganda grapple with Burkitt lymphomaThe Lancet Oncology, 2008
- Treatment of B‐cell lymphoma with LMB modified protocols in Africa—report of the French‐African Pediatric Oncology Group (GFAOP)Pediatric Blood & Cancer, 2008
- Malawi pilot study of Burkitt lymphoma treatmentMedical and Pediatric Oncology, 2003
- The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemiaBlood, 2001